Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00611260 · ClinicalTrials.gov registry record · NA

Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT00611260: Completed NA study, sponsored by University of California, Davis.

NCT00611260 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00611260, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

This is a trial to examine the effects of meditation on the incidence of ventricular arrhythmias and the psychological profiles in patients with implanted cardiac defibrillators. We wish to test the following hypotheses: 1. Vipassana meditation reduces the incidence of atrial and ventricular arrhythmias in patients with congestive heart failure. 2. Vipassana meditation improves the psychological profile in patients with CHF. In this study, subjects meeting the inclusion and exclusion criteria will be recruited into the study after obtaining informed consent. The subjects will then be randomized into either an experimental group ( Meditation) or into a control group (usual care).

Interventions

  • OTHER Standard Medical Care
  • BEHAVIORAL Vipassana Meditation practice and instruction

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2007-04
Est. Completion 2012-02
Phase NA
University of California, Davis

657 total trials

What the finished NCT00611260 record still lists

NCT00611260 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Medical Care is the first listed.

NCT00611260 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00611260 about?

NCT00611260 is a clinical study titled "Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation". This is a trial to examine the effects of meditation on the incidence of ventricular arrhythmias and the psychological profiles in patients with implanted cardiac defibrillators. We wish to test the following hypotheses: 1. Vipassana meditation reduces the incidence of atrial and ventricular arrhy...

What is the current status of trial NCT00611260?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2007-04. Estimated completion is 2012-02.

What interventions are being tested in trial NCT00611260?

The interventions under investigation include: Standard Medical Care (OTHER), Vipassana Meditation practice and instruction (BEHAVIORAL).

Who is sponsoring clinical trial NCT00611260?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00611260's enrollment target sits among peer trials

27 1708th of 2000 higher than 291 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00611260, the US trial registry maintained by the National Library of Medicine. NCT00611260 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.